Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Other Non Operating Income (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Other Non Operating Income for 14 consecutive years, with $190000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 35.71% to $190000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, up 383.17% year-over-year, with the annual reading at -$594000.0 for FY2024, 422.83% down from the prior year.
  • Other Non Operating Income for Q4 2025 was $190000.0 at Aytu Biopharma, down from $3.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $3.8 million in Q3 2025, with the low at -$5.9 million in Q3 2023.
  • Average Other Non Operating Income over 5 years is $344526.3, with a median of $140000.0 recorded in 2024.
  • The sharpest move saw Other Non Operating Income skyrocketed 5577.5% in 2022, then tumbled 17257.14% in 2023.
  • Over 5 years, Other Non Operating Income stood at -$257000.0 in 2021, then skyrocketed by 645.91% to $1.4 million in 2022, then plummeted by 93.16% to $96000.0 in 2023, then skyrocketed by 45.83% to $140000.0 in 2024, then surged by 35.71% to $190000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at $190000.0, $3.8 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.